Cyclooxygenase 2 Inhibitors Concept

subject area of

• A Phase III Randomized Trial of the Timing of Meloxicam With Iodine-125 Prostate Brachytherapy  Journal Articles
• A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects  Journal Articles
• A selective inhibitor of cyclooxygenase-2 reverses endotoxin-induced pyretic responses in non-human primates  Journal Articles
• Acid-NSAID/Aspirin Interaction in Peptic Ulcer Disease  Journal Articles
• Analysis of Prostaglandin G/H Synthase-2 Inhibition Using Peroxidase-Induced Luminol Luminescence  Journal Articles
• Approach to managing musculoskeletal pain: acetaminophen, cyclooxygenase-2 inhibitors, or traditional NSAIDs?  Journal Articles
• Association of myocardial infarctions with COX-2 inhibition may be related to immunomodulation towards a Th1 response resulting in atheromatous plaque instability: an evidence-based interpretation  Journal Articles
• Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitor  Journal Articles
• Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks  Journal Articles
• Complementary studies of the gastrointestinal safety of the cyclo‐oxygenase‐2‐selective inhibitor etoricoxib  Journal Articles
• Consensus Development Conference on the Use of Nonsteroidal Anti-Inflammatory Agents, Including Cyclooxygenase-2 Enzyme Inhibitors and Aspirin  Journal Articles
• Cyclooxygenase-2 (COX-2) in acute myocardial infarction: cellular expression and use of selective COX-2 inhibitor  Conferences
• Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Counterpoint  Journal Articles
• Design and synthesis of [ 125 I]Pyricoxib: A novel 125 I-labeled cyclooxygenase-2 (COX-2) inhibitors  Journal Articles
• Differential Effect of a Selective Cyclooxygenase-2 Inhibitor Versus Indomethacin on Renal Blood Flow in Conscious Volume-Depleted Dogs  Journal Articles
• Does Celecoxib Potentiate the Anticoagulant Effect of Warfarin? A Randomized, Double-Blind, Controlled Trial  Journal Articles
• Does the long-term use of aspirin decrease the risk of death due to cancer?  Journal Articles
• Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.  Journal Articles
• Function of cyclo‐oxygenase‐1 and cyclo‐oxygenase‐2 in the ductus arteriosus from foetal lamb: differential development and change by oxygen and endotoxin  Journal Articles
• Global Gastrointestinal Safety Profile of Etoricoxib and Lumiracoxib  Journal Articles
• In high-risk patients with arthritis and previous upper GI bleeding, celecoxib vs naproxen reduced recurrent bleeding  Journal Articles
• Incremental Cost-Effectiveness Analysis Comparing Rofecoxib with Nonselective NSAIDs in Osteoarthritis  Journal Articles
• Inhibition of COX pathway in experimental myocardial infarction  Journal Articles
• Inhibition of COX pathway in experimental myocardial infarction.  Journal Articles
• Inhibition of Cyclooxygenase-2 Improves Cardiac Function in Myocardial Infarction  Journal Articles
• International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding  Journal Articles
• Motion-Cyclo-oxygenase-2 Selective Nonsteroidal Anti-Inflammatory Drugs are as Safe as Placebo for the Stomach: Arguments for the Motion  Journal Articles
• Nonsteroidal Antiinflammatory Drug-Related Injury to the Gastrointestinal Tract: Clinical Picture, Pathogenesis, and Prevention  Journal Articles
• Peptic ulcer disease today  Journal Articles
• Preoperative celecoxib in noncardiac surgery  Journal Articles
• Radiochemistry on electrodes: Synthesis of an 18F-labelled and in vivo stable COX-2 inhibitor  Journal Articles
• Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.  Journal Articles
• Rofecoxib associated with diaphragm disease  Journal Articles
• Rofecoxib does not appear to increase the risk of venous thromboembolism: A systematic review of the literature  Journal Articles
• Selective Cyclooxygenase-2 Inhibitors as Potential Therapeutic Agents for Inflammatory Diseases  Journal Articles
• Signature Celebration of Gastroenterology , Colorectal Cancer  Journal Articles
• The Vioxx® legacy: Enduring lessons from the not so distant past  Journal Articles
• The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor  Journal Articles
• The effects of coxib formulary restrictions on analgesic use and cost: Regional evidence from Canada  Journal Articles
• The efficacy of oral non-steroidal anti-inflammatory drugs for rotator cuff tendinopathy: A systematic review and meta-analysis  Journal Articles
• The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events  Journal Articles